Clinical Laserthermia Systems

Clinical Laserthermia Systems to host Strategy Update Event on February 15

The Strategy Update is a hybrid event. Participants are welcome to participate either physically, at the Redeye office, Mäster Samuelsgatan 42, 10th floor, Stockholm, Sweden, or digitally.

 

Dan J. Mogren, CEO of CLS, and members from the management team will present the company´s strategic priorities and its commercial roll-out. The presentations will be held in English.

 

Following the presentations, there will be a Q&A session moderated by Redeye analyst Gustaf Meyer. Viewers will have the opportunity to ask questions via the webcast chat or send questions beforehand to info@clinicallaser.se.

 

Registrate to participate physically here: https://bit.ly/408qGSF. No pre-registration is required to watch the webcast. 

 

Follow the event via webcast here: https://www.redeye.se/events/872234/strategy-update-cls

 

Webcast recoding will be available after the event on clinicallaser.se.

 

 

The information was submitted for publication, through the agency of the contact person set out below on 8 February 2023.

 

 

For more information, please contact:

Dan J. Mogren, CEO, Clinical Laserthermia Systems AB (publ)

Phone: +46 (0) 70-590 11 40
E-mail: dan.mogren@clinicallaser.com

 

 

About CLS

Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG®|Thermal Therapy Systems, including Thermoguide Workstation and sterile disposables, for minimally invasive treatment of cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. The products  are  marketed  for  image-guided  laser  ablation  and  used in studies for  treatment  with  imILT®, the  Company's  interstitial  laser  thermotherapy  for immunostimulant ablation with potential abscopal  effects. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. The Certified Advisor (CA) is FNCA Sweden AB, Tel: +46 8 528 00 399. E-mail: info@fnca.se.

 

For more information about CLS, please visit the Company's website: clinicallaser.se

 

Datum 2023-02-08, kl 08:30
Källa Cision
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet